Puma Biotechnology Inc expected to post earnings of 4 cents a share - Earnings Preview

Puma Biotechnology

04/08/2026 23:53

Puma Biotechnology Inc PBYI.OQ PBYI.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Los Angeles California-based  company is expected to report a 1.1% increase in revenue to $53 million from $52.4 million a year ago, according to the estimate from one analyst, based on LSEG data.The company's guidance on May 7 2026, for the period ended June 30, was for revenue between $52.00 million and $55.00 million.
​LSEG's mean analyst estimate for Puma Biotechnology Inc is for earnings of 4 cents per share. 
The one available analyst rating on the shares is "hold".  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Puma Biotechnology Inc is $5.00, about 35.9% below its last closing price of $7.80
This summary was machine generated August 4 at 22:53 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)